Total Payments
$1,234
2024 Payments
$80.46
Companies
11
Transactions
24
Medicare Patients
446
Medicare Billing
$276,550
Payment Breakdown by Category
Food & Beverage$1,130 (91.5%)
Education$104.49 (8.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,130 | 22 | 91.5% |
| Education | $104.49 | 2 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $358.73 | 9 | $0 (2023) |
| Amgen Inc. | $156.04 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $124.45 | 2 | $0 (2017) |
| Medtronic, Inc. | $120.00 | 1 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $102.97 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $92.98 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $73.67 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $69.25 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $56.30 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $54.63 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80.46 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($34.85) |
| 2023 | $232.11 | 4 | Bayer Healthcare Pharmaceuticals Inc. ($102.97) |
| 2022 | $369.33 | 5 | AstraZeneca Pharmaceuticals LP ($193.03) |
| 2020 | $37.86 | 2 | AstraZeneca Pharmaceuticals LP ($37.86) |
| 2019 | $138.30 | 2 | Janssen Pharmaceuticals, Inc ($69.25) |
| 2018 | $122.50 | 2 | Amgen Inc. ($122.50) |
| 2017 | $253.46 | 6 | Merck Sharp & Dohme Corporation ($124.45) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.61 | General |
| 01/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: DIABETES | ||||||
| 12/19/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.02 | General |
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $73.67 | General |
| Category: IMMUNOLOGY | ||||||
| 01/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $102.97 | General |
| Category: Cardio-renal | ||||||
| 06/16/2022 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Catheters | ||||||
| 05/12/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $72.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/16/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $56.30 | General |
| Category: Cardiovascular | ||||||
| 02/07/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/22/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/27/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $69.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $69.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2018 | Amgen Inc. | — | Education | In-kind items and services | $4.50 | General |
| 06/14/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $118.00 | General |
| Category: Nephrology | ||||||
| 08/24/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/20/2017 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: Nephrology | ||||||
| 05/04/2017 | AstraZeneca Pharmaceuticals LP | ONGLYZA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $104.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/02/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $58.13 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 47 | 209 | $60,580 | $41,499 |
| 2022 | 5 | 90 | 275 | $60,260 | $45,692 |
| 2021 | 4 | 106 | 351 | $81,700 | $56,745 |
| 2020 | 8 | 203 | 794 | $179,070 | $132,615 |
Total Patients
446
Total Services
1,629
Medicare Billing
$276,550
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 14 | 136 | $54,100 | $37,204 | 68.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 41 | $3,280 | $2,552 | 77.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 32 | $3,200 | $1,742 | 54.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 17 | 138 | $41,400 | $32,581 | 78.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 13 | 31 | $9,300 | $7,143 | 76.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 52 | $4,160 | $2,931 | 70.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 28 | $2,800 | $1,633 | 58.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 26 | $2,600 | $1,404 | 54.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 23 | 200 | $68,100 | $48,051 | 70.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 75 | $6,000 | $4,204 | 70.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 39 | $3,900 | $2,345 | 60.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 37 | $3,700 | $2,145 | 58.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 41 | 419 | $125,700 | $97,193 | 77.3% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 21 | 93 | $27,900 | $18,070 | 64.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 37 | 141 | $11,280 | $8,261 | 73.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 32 | $3,200 | $2,241 | 70.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 46 | $4,600 | $2,112 | 45.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 19 | 30 | $2,550 | $1,789 | 70.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 18 | $2,340 | $1,758 | 75.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 15 | $1,500 | $1,190 | 79.4% |
About Dr. Alfredo Ramirez, M.D
Dr. Alfredo Ramirez, M.D is a Nephrology healthcare provider based in Mayaguez, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528005162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alfredo Ramirez, M.D has received a total of $1,234 in payments from pharmaceutical and medical device companies, with $80.46 received in 2024. These payments were reported across 24 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,130).
As a Medicare-enrolled provider, Ramirez has provided services to 446 Medicare beneficiaries, totaling 1,629 services with total Medicare billing of $276,550. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Mayaguez, PR
- Active Since 06/01/2006
- Last Updated 05/03/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528005162
Products in Payments
- Parsabiv (Biological) $151.54
- LOKELMA (Drug) $149.35
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $120.00
- ZEPATIER (Drug) $104.94
- Kerendia (Drug) $102.97
- BRILINTA (Drug) $99.99
- FARXIGA (Drug) $94.51
- JARDIANCE (Drug) $92.98
- BENLYSTA (Biological) $73.67
- INVOKANA (Drug) $69.25
- ELIQUIS (Drug) $56.30
- PURIFIED CORTROPHIN GEL (Drug) $25.00
- JANUVIA (Drug) $19.51
- ONGLYZA (Drug) $14.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Mayaguez
Dr. William Hurtado-Santiago, Md, MD
Nephrology — Payments: $141,130
Nephrology $141,130
Enrique Lefevre, Md, MD
Nephrology — Payments: $2,901
Nephrology $2,901
Bryan Pagan Rivera, M.d, M.D
Nephrology — Payments: $2,821
Nephrology $2,821
Efrain Flores De Hostos, Md, MD
Nephrology — Payments: $2,684
Nephrology $2,684
Jorge Weber Acevedo, Md, MD
Nephrology — Payments: $2,067
Nephrology $2,067
Gerardo Medina Caban, Md, MD
Nephrology — Payments: $2,004
Nephrology $2,004